Cargando…
New Tools for Molecular Therapy of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, arising from neoplastic transformation of hepatocytes or liver precursor/stem cells. HCC is often associated with pre-existing chronic liver pathologies of different origin (mainly subsequent to HBV and HCV infections), such as...
Autores principales: | Marchetti, Alessandra, Bisceglia, Francesca, Cozzolino, Angela M., Tripodi, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548255/ https://www.ncbi.nlm.nih.gov/pubmed/28943628 http://dx.doi.org/10.3390/diseases3040325 |
Ejemplares similares
-
TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure
por: De Santis Puzzonia, Marco, et al.
Publicado: (2016) -
TGFβ Impairs HNF1α Functional Activity in Epithelial-to-Mesenchymal Transition Interfering With the Recruitment of CBP/p300 Acetyltransferases
por: Bisceglia, Francesca, et al.
Publicado: (2019) -
Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
por: Laface, Carmelo, et al.
Publicado: (2022) -
Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
por: Cicchini, Carla, et al.
Publicado: (2015) -
Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes
por: Cozzolino, Angela Maria, et al.
Publicado: (2016)